Medical stents are small, expandable mesh tubes used to prop open narrowed or blocked blood vessels and other anatomical passages. They are essential in treating coronary artery disease, peripheral artery disease, and other conditions. The market for medical stents is expanding steadily, driven by the rising prevalence of cardiovascular diseases, an aging population, and technological advancements.

According to recent market analysis, the global Medical Stents Market was valued at approximately USD 8.7 billion in 2025 and is projected to reach USD 12.3 billion by 2035, growing at a CAGR of 3.5%. This growth reflects both the increasing burden of cardiovascular diseases and the medical device industry's investment in innovative stent technologies.

Rising Prevalence of Cardiovascular Diseases

The primary driver is the rising prevalence of cardiovascular diseases (CVDs), which remain a leading cause of mortality worldwide. The World Health Organization reports that CVDs account for approximately 32% of all global deaths. As the population ages and risk factors like obesity and diabetes become more common, the number of patients requiring stent procedures increases, driving demand.

Technological Advancements in Stent Design

Technological innovation is also shaping the market. The development of drug-eluting stents (DES) has significantly reduced the risk of restenosis compared to bare-metal stents. Additionally, bioresorbable stents, which dissolve over time, are emerging as a promising alternative. These innovations are driving adoption and market growth.

People Also Ask

What is the market size of medical stents?
The medical stents market was valued at approximately USD 8.7 billion in 2025 and is projected to reach USD 12.3 billion by 2035, growing at a CAGR of 3.5%.

What are the key types of medical stents?
Key types include drug-eluting stents, bare-metal stents, bio-absorbable stents, and covered stents.

Regional dynamics further shape the market. North America leads with a valuation of USD 4 billion in 2024, supported by advanced healthcare infrastructure and high procedure volumes. Europe follows closely, while Asia-Pacific is the fastest-growing region, driven by increasing healthcare investments and rising CVD prevalence.

Tags: #MedicalStents #CardiovascularDisease #DrugElutingStents #CoronaryArteryDisease #MedicalDevices